CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China flag China · Delayed Price · Currency is CNY
30.37
+0.43 (1.44%)
Apr 30, 2026, 3:07 PM CST

SHE:300765 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
628.5772.17872.083,7702,1961,244
Short-Term Investments
-208.35355.53---
Trading Asset Securities
350.3385.39470.09--413.59
Cash & Short-Term Investments
978.81,3661,6983,7702,1961,658
Cash Growth
-24.64%-19.54%-54.97%71.71%32.43%13.51%
Accounts Receivable
817.92693.47559.76560.78716.75508.94
Other Receivables
16.710.692.051.551.561.37
Receivables
834.62704.16561.81562.32718.31510.31
Inventory
457.12497.8398.67224.82238.13262
Other Current Assets
499.47285.28144.2260.2938.4756.92
Total Current Assets
2,7702,8532,8024,6183,1912,487
Property, Plant & Equipment
2,9012,8002,6682,3121,055926.42
Long-Term Investments
253.02259.22264.45267.07253.49243.19
Other Intangible Assets
217.25218.85225.21231.5950.4252.81
Long-Term Deferred Tax Assets
18.4821.8321.6117.3618.8812.5
Other Long-Term Assets
50.01123.0340.2926.3315.919.06
Total Assets
6,2106,2766,0227,4724,5843,741
Accounts Payable
715.62721.62396.211,264178.75129.17
Accrued Expenses
31.7758.1232.2266.1166.2454.57
Short-Term Debt
-3.2----
Current Portion of Long-Term Debt
----0.22-
Current Portion of Leases
0.80.790.840.81-0.84
Current Income Taxes Payable
5.37.317.1528.3634.7714.95
Current Unearned Revenue
23.126.0918.6819.868.2630.37
Other Current Liabilities
1,9951,892969.18524.42234.52178.75
Total Current Liabilities
2,7722,7091,4341,904582.77408.64
Long-Term Debt
10---19.8-
Long-Term Leases
1.681.66-0.84--
Long-Term Unearned Revenue
221.41239.9290.4984.1637.2134.27
Long-Term Deferred Tax Liabilities
2.061.871.40.020.060.67
Other Long-Term Liabilities
532.43528.46----
Total Liabilities
3,5403,4811,5261,989639.84443.58
Common Stock
1,4051,4051,4051,171618.93546
Additional Paid-In Capital
187.02181.28977.272,1251,1381,211
Retained Earnings
1,3041,3981,6671,9882,1771,533
Treasury Stock
-321.03-321.03-321.03-4.25--
Comprehensive Income & Other
2.074.262.51.980.72-1.2
Total Common Equity
2,5772,6673,7315,2813,9363,289
Minority Interest
93.35127.92765.39202.458.598.26
Shareholders' Equity
2,6702,7954,4965,4833,9443,298
Total Liabilities & Equity
6,2106,2766,0227,4724,5843,741
Total Debt
12.475.650.841.6520.020.84
Net Cash (Debt)
966.331,3601,6973,7692,1761,657
Net Cash Growth
-25.56%-19.84%-54.97%73.21%31.29%13.45%
Net Cash Per Share
0.690.981.212.701.631.24
Filing Date Shares Outstanding
1,3931,3931,3931,4051,3371,179
Total Common Shares Outstanding
1,3931,3931,3931,4051,3371,179
Working Capital
-2.04144.011,3682,7142,6082,079
Book Value Per Share
1.851.922.683.762.942.79
Tangible Book Value
2,3602,4483,5055,0493,8853,237
Tangible Book Value Per Share
1.691.762.523.592.912.74
Buildings
-1,1881,020973.56609.24430.75
Machinery
-2,0271,9391,821925.79701.65
Construction In Progress
-681.25620.23228.7170.74294.97
Source: S&P Global Market Intelligence. Standard template. Financial Sources.